CN101217868A - 用于皮肤护理的组合物和方法 - Google Patents

用于皮肤护理的组合物和方法 Download PDF

Info

Publication number
CN101217868A
CN101217868A CNA2006800220611A CN200680022061A CN101217868A CN 101217868 A CN101217868 A CN 101217868A CN A2006800220611 A CNA2006800220611 A CN A2006800220611A CN 200680022061 A CN200680022061 A CN 200680022061A CN 101217868 A CN101217868 A CN 101217868A
Authority
CN
China
Prior art keywords
vitamin
nicotinamide
cadpr
skin
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800220611A
Other languages
English (en)
Chinese (zh)
Inventor
艾维凯姆·海瑞尔
泽夫·艾文-陈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dermipsor Ltd
Original Assignee
Dermipsor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dermipsor Ltd filed Critical Dermipsor Ltd
Publication of CN101217868A publication Critical patent/CN101217868A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
CNA2006800220611A 2005-05-10 2006-05-10 用于皮肤护理的组合物和方法 Pending CN101217868A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67932905P 2005-05-10 2005-05-10
US60/679,329 2005-05-10

Publications (1)

Publication Number Publication Date
CN101217868A true CN101217868A (zh) 2008-07-09

Family

ID=37396969

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800220611A Pending CN101217868A (zh) 2005-05-10 2006-05-10 用于皮肤护理的组合物和方法

Country Status (7)

Country Link
US (1) US8034788B2 (https=)
EP (1) EP1879449A4 (https=)
JP (1) JP2008540513A (https=)
CN (1) CN101217868A (https=)
AU (1) AU2006245282A1 (https=)
CA (1) CA2608021A1 (https=)
WO (1) WO2006120681A2 (https=)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106265695A (zh) * 2009-08-14 2017-01-04 博格有限责任公司 用于治疗脱发的维生素d3及其类似物
CN111936149A (zh) * 2018-04-02 2020-11-13 梁美京 用于预防或治疗毛发脱落或者促进毛发生长的药物组合物或化妆品组合物
CN112315837A (zh) * 2016-01-11 2021-02-05 宝洁公司 处理皮肤状况的方法以及用于其的组合物
CN114126623A (zh) * 2019-05-17 2022-03-01 宾夕法尼亚大学董事会 治疗肥胖和/或皮肤紊乱的方法和组合物
CN118384058A (zh) * 2024-04-08 2024-07-26 云南贝泰妮生物科技集团股份有限公司 烟酰胺在制备预防和/或治疗皮肤光老化护肤品和药物中的应用

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
US9173835B2 (en) 2005-05-10 2015-11-03 Dermipsor Ltd. Compositions and methods for treating hyperproliferative epidermal diseases
WO2008131256A1 (en) * 2007-04-19 2008-10-30 Trinity Laboratories Inc. Improved treatments for premature ejaculation in humans
WO2009022338A2 (en) * 2007-08-16 2009-02-19 Saher Hamed Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications
FR2925313A1 (fr) * 2007-12-19 2009-06-26 Oreal Utilisation cosmetique de proteines de type plakoglobine
FR2925314B1 (fr) * 2007-12-19 2012-11-23 Oreal Utilisation cosmetique de proteines de type transglutaminase 3
FR2936421B1 (fr) * 2008-09-29 2011-02-11 Bouill Mariya Le Produit de beaute et de soin pour faire disparaitre les rides du visage, empecher leur apparition et maintenir la tonicite de la peau
RU2397770C1 (ru) * 2008-12-30 2010-08-27 Закрытое акционерное общество Фармацевтическое научно-производственное предприятие "Ретиноиды" Поливитаминная мазь для смягчения, питания и заживления кожи и способ ее получения
US20120322776A1 (en) * 2009-12-22 2012-12-20 Leo Pharma A/S Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
WO2011087525A1 (en) * 2010-01-17 2011-07-21 The Procter & Gamble Company Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin for individuals in a selected population
AU2018216043B2 (en) * 2017-02-06 2020-02-27 3Skin As Sunscreen composition
KR20210011964A (ko) 2018-07-03 2021-02-02 더 프록터 앤드 갬블 캄파니 피부 병태를 치료하는 방법
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
CN115843238B (zh) 2020-06-01 2025-06-10 宝洁公司 改善维生素b3化合物渗透到皮肤中的方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120722A (en) * 1984-02-08 1992-06-09 Hoffmann-La Roche Inc. Trihydroxy-cholecacliferol and trihydroxy-ergocalciferol for treating leukemia
JPH07100685B2 (ja) * 1985-08-02 1995-11-01 レオ・ファ−マシュ−ティカル・プロダクツ・リミテッド・エイ／エス（レ−ベンス・ケミスケ・ファブリック・プロデュクチオンスアクチ−セルスカブ） 新規ビタミンｄ類似体
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US4851401A (en) * 1988-07-14 1989-07-25 Wisconsin Alumni Research Foundation Novel cyclopentano-vitamin D analogs
CA1333616C (en) 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
GB9007236D0 (en) 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
ATE143007T1 (de) * 1991-07-05 1996-10-15 Duphar Int Res Vitamin-d derivat, verfahren zu dessen herstellung sowie zwischenprodukte dafür
DE4141746A1 (de) * 1991-12-13 1993-06-17 Schering Ag 20-methyl-substituierte vitamin d-derivate
US5237629A (en) * 1992-03-19 1993-08-17 The United States Of America As Represented By The United States Department Of Energy Digitally controlled distributed phase shifter
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
US5747479A (en) * 1996-01-03 1998-05-05 Hoffmann-La Roche Inc. Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
IL126802A0 (en) * 1996-05-02 1999-08-17 Duphar Int Res Vitamin d analogs and methods of preparing these compounds
US5811414A (en) * 1997-05-16 1998-09-22 Hoffmann-La Roche Inc. Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
US6262041B1 (en) * 1998-04-06 2001-07-17 Bertek Pharmaceuticals, Inc. Use of vitamin D analogs to treat conditions related to increased oxidative stress
US20010002396A1 (en) * 1998-07-16 2001-05-31 Charles Achkar Compositions and methods of treating skin conditions
US6552009B2 (en) * 1998-07-16 2003-04-22 Gentrix Llc Compositions and methods of treating abnormal cell proliferation
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
PT3146969T (pt) * 1999-04-23 2018-10-18 Leo Pharma As Composição farmacêutica para aplicação dérmica para uso no tratamento da psoríase compreendendo vitamina d e um corticosteroide
FR2801305B1 (fr) * 1999-11-24 2002-12-06 Galderma Res & Dev Analogues de la vitamine d
IL133976A (en) * 2000-01-11 2006-09-05 Dermipsor Ltd Agents for the treatment of skin disorders
WO2004006887A2 (en) * 2002-07-11 2004-01-22 Dermipsor Ltd. Composition and methods for the treatment of skin disorders

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106265695A (zh) * 2009-08-14 2017-01-04 博格有限责任公司 用于治疗脱发的维生素d3及其类似物
CN106265695B (zh) * 2009-08-14 2021-05-07 博格有限责任公司 用于治疗脱发的维生素d3及其类似物
CN112315837A (zh) * 2016-01-11 2021-02-05 宝洁公司 处理皮肤状况的方法以及用于其的组合物
CN112315837B (zh) * 2016-01-11 2021-12-03 宝洁公司 处理皮肤状况的方法以及用于其的组合物
CN115414273A (zh) * 2016-01-11 2022-12-02 宝洁公司 处理皮肤状况的方法以及用于其的组合物
CN115414273B (zh) * 2016-01-11 2024-01-30 宝洁公司 处理皮肤状况的方法以及用于其的组合物
CN111936149A (zh) * 2018-04-02 2020-11-13 梁美京 用于预防或治疗毛发脱落或者促进毛发生长的药物组合物或化妆品组合物
CN111936149B (zh) * 2018-04-02 2023-09-29 梁美京 用于预防或治疗毛发脱落或者促进毛发生长的药物组合物或化妆品组合物
CN114126623A (zh) * 2019-05-17 2022-03-01 宾夕法尼亚大学董事会 治疗肥胖和/或皮肤紊乱的方法和组合物
CN118384058A (zh) * 2024-04-08 2024-07-26 云南贝泰妮生物科技集团股份有限公司 烟酰胺在制备预防和/或治疗皮肤光老化护肤品和药物中的应用

Also Published As

Publication number Publication date
EP1879449A2 (en) 2008-01-23
CA2608021A1 (en) 2006-11-16
JP2008540513A (ja) 2008-11-20
EP1879449A4 (en) 2009-12-16
US20080312181A1 (en) 2008-12-18
US8034788B2 (en) 2011-10-11
WO2006120681A3 (en) 2007-01-25
WO2006120681A2 (en) 2006-11-16
AU2006245282A1 (en) 2006-11-16

Similar Documents

Publication Publication Date Title
US8034788B2 (en) Composition and methods for skin care
DK1879595T3 (en) Preparations and Methods for the Treatment of Hyperproliferative Epidermal Diseases
US6623728B2 (en) Cosmetic skin care compositions and containing gum mastic
RU2562140C2 (ru) Композиция и способ для лечения признаков старения кожи
US20100247693A1 (en) Cosmetic formulation to treat rosacea telangiectasia
US20160175223A1 (en) Anti-aging compositions comprising bile acid-fatty acid conjugates
HK1211866A1 (en) Antioxidant compositions and methods of using the same
EP1565189A1 (en) Anti-aging skin care composition and uses thereof
JP2004203893A (ja) ベツリン酸を含む化粧品組成物
EP3030229B1 (en) Anti-acne compositions comprising bile acid-fatty acid conjugates
EP1000613A2 (en) Composition against the ageing and its use
TW201542234A (zh) 用於皮膚保養之局部投與方法及組合物
US20240148632A1 (en) Topical compositions containing n-acyl dipeptide derivatives and glycolic acid
HK1003028A1 (en) Skin care composition
HK1003028B (en) Skin care composition
EP2133066A1 (en) Cosmetic and dermatological composition containing a mixture of retinol derivatives and tocotrienols.
JP2007284430A (ja) グルタチオン産生促進剤
US20240423897A1 (en) Longevity serum
IL187237A (en) Preparations containing calcipotriol and nicotinamide for use in skin care
US20240423899A1 (en) Longevity moisturizing cream
KR102957774B1 (ko) 카르니틴살리실레이트(ca-sa)를 유효성분으로 포함하는 피부 개선용 조성물
US20250049685A1 (en) Collagen lotion formulations and methods of use thereof
US20250049684A1 (en) Collagen cream formulations and methods of use thereof
US20250049686A1 (en) Collagen serum formulations and methods of use thereof
US20240423898A1 (en) Longevity eye cream

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20080709